Catalent, Inc. (CTLT) Financial Statements (2023 and earlier)

Company Profile

Business Address 14 SCHOOLHOUSE ROAD
SOMERSET, NJ 08873
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

6/30/2022
12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments449849896953345410307
Cash and cash equivalents449849896953345410288
Short-term investments      19
Receivables1,0518711,012838716556489
Inventory, net of allowances, customer advances and progress billings702688563324257209185
Inventory702688563324257209185
Prepaid expense61544629191924
Contract with customer, asset 308   
Disposal group, including discontinued operation  47    
Other current assets70614731241544
Other undisclosed current assets583143307119353112
Total current assets:2,9162,9742,9182,2931,3961,2401,060
Noncurrent Assets
Property, plant and equipment3,1272,7272,5241,9011,5371,271996
Intangible assets, net (including goodwill)4,0664,1583,3363,3593,1521,9421,317
Goodwill3,0063,0262,5192,4712,2211,3971,044
Intangible assets, net (excluding goodwill)1,0601,132817889931545273
Regulated entity, other noncurrent assets      12
Deferred costs      15
Deferred income tax assets 65  
Other noncurrent assets349279268174614528
Other undisclosed noncurrent assets49 6649393327
Total noncurrent assets:7,5917,2296,1945,4844,7883,2912,395
TOTAL ASSETS:10,50710,2039,1127,7776,1844,5313,454
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0411,0161,121820594505444
Accounts payable421363385321256192163
Accrued liabilities620653736499338313281
Debt31297573777225
Total current liabilities:1,0721,0451,196893671577469
Noncurrent Liabilities
Long-term debt and lease obligation, including:4,1714,1913,1662,9452,8832,6492,055
Finance lease, liability217 178128
Operating lease, liability85 7388
Other undisclosed long-term debt and lease obligation3,8694,1912,9152,7292,8832,6492,055
Liabilities, other than long-term debt267297312339268186175
Liability, pension and other postretirement and postemployment benefits103127137135144132130
Other liabilities1641701752041245446
Other undisclosed noncurrent liabilities20218916494743332
Total noncurrent liabilities:4,6404,6773,6423,3783,2252,8682,262
Total liabilities:5,7125,7224,8384,2713,8963,4442,731
Temporary equity, carrying amount  359607   
Stockholders' equity
Stockholders' equity attributable to parent, including:4,7954,4813,9152,8991,6821,087724
Preferred stock   00  
Additional paid in capital4,6494,6154,2053,8192,7572,2831,992
Accumulated other comprehensive loss(394)(345)(317)(386)(354)(326)(314)
Retained earnings (accumulated deficit)53820925(535)(723)(872)(956)
Other undisclosed stockholders' equity attributable to parent2222111
Total stockholders' equity:4,7954,4813,9152,8991,6821,087724
Other undisclosed liabilities and equity    607  
TOTAL LIABILITIES AND EQUITY:10,50710,2039,1127,7776,1844,5313,454

Income Statement (P&L) ($ in millions)

6/30/2022
12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
Revenues4,8284,4843,9983,0942,5182,4632,075
Revenue, net2,4632,075
Cost of revenue
(Cost of Goods and Services Sold)
(3,188)(2,950)(2,646)(2,111)(1,713)(1,711)(1,421)
Gross profit:1,6401,5341,352983805753655
Operating expenses(885)(800)(706)(583)(526)(473)(411)
Other undisclosed operating income (loss)1185182(6)(5)(9)(10)
Operating income:756919828394274271234
Nonoperating expense(28)(46)(3)(8)(3)(8)(9)
Investment income, nonoperating(10)17317968(12)(21)
Foreign currency transaction gain (loss), before tax(30)(34)4(2)13(8)
Other nonoperating income (expense)9620513(1) 
Interest and debt expense353(6)(4)(3)(2)
Other undisclosed loss from continuing operations before equity method investments, income taxes (60)(113)(120)(107)(109)(88)
Income from continuing operations before equity method investments, income taxes:731819715260160152136
Other undisclosed loss from continuing operations before income taxes(126)(62)     
Income from continuing operations before income taxes:605757715260160152136
Income tax expense(86)(152)(130)(40)(23)(68)(26)
Net income attributable to parent:51960458522113784110
Other undisclosed net loss available to common stockholders, basic(16)(41)(56)(48)(5)  
Net income available to common stockholders, diluted:50356352917313284110

Comprehensive Income ($ in millions)

6/30/2022
12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
Net income:51960458522113784110
Other comprehensive income (loss)(77)(16)69(32)(28)(12)(8)
Comprehensive income, net of tax, attributable to parent:44258965418810972101

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: